| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 0 | 12.648 | 17.306 | 16.473 | 10.236 | 5.347 | 5.675 |
| Total Income - EUR | - | - | 0 | 4.402 | 18.669 | 23.221 | 22.257 | 16.038 | 9.424 | 10.076 |
| Total Expenses - EUR | - | - | 92 | 21.221 | 22.961 | 21.112 | 20.754 | 14.331 | 9.668 | 9.883 |
| Gross Profit/Loss - EUR | - | - | -92 | -16.819 | -4.293 | 2.108 | 1.503 | 1.707 | -244 | 193 |
| Net Profit/Loss - EUR | - | - | -92 | -16.819 | -4.418 | 1.949 | 1.339 | 1.545 | -244 | 184 |
| Employees | - | - | 0 | 2 | 2 | 2 | 2 | 1 | 0 | 0 |
Check the financial reports for the company - Ophtaforce Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 38.320 | 31.502 | 25.668 | 20.686 | 16.323 | 11.860 | 7.405 |
| Current Assets | - | - | 44 | 827 | 1.212 | 1.996 | 2.024 | 488 | 468 | 726 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 189 | 392 |
| Cash | - | - | 44 | 827 | 1.212 | 1.996 | 2.024 | 488 | 279 | 334 |
| Shareholders Funds | - | - | -49 | -16.867 | -20.958 | -18.612 | -16.861 | -15.368 | -18.981 | -18.691 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 92 | 18.334 | 22.742 | 21.847 | 21.466 | 19.820 | 19.649 | 19.570 |
| Income in Advance | - | - | 0 | 37.680 | 30.931 | 24.430 | 18.104 | 12.358 | 11.660 | 7.252 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ophtaforce Srl